Naldemedine was safe and effective and reduced health care resource utilization among adults with opioid-induced constipation and chronic noncancer pain.

Reply to: Reproducibility of Clinically Meaningful Change in Physical Capacity Tested by Online 6-Minute Walk Test The article by Hamano et al entitled “Naldemedine for Opioid-Induced Constipation in ...

RELISTOR injection is also used to treat constipation caused by opioids in adults with advanced illness or pain caused by active cancer and who need increases in their opioid dose for comfort care.

American Century Companies Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) ...

KLP Kapitalforvaltning AS bought a new stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the ...

Additionally, transdermal opioid formulations ... For chemotherapy-induced vomiting, granisetron is an option. However, it may lead to headaches, constipation, or drowsiness.

Purpose. Published reports on placebo-controlled clinical trials and other studies investigating the use of pure opioid antagonists for the prevention and treatment of opioid-induced pruritus (OIP ...

This includes opioid-induced respiratory depression, which occurs when an opioid suppresses a person's drive to breathe, sometimes resulting in death. Naloxone works by replacing opioids ...

Did we get it wrong about eggs and constipation too? Here's what the mixed bag of evidence tells us. Constipation means different things to different people, and there are many different types.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Thursday, April 10, 2025. Let’s ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.